![Ulf Bladin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulf Bladin
Amministratore Delegato presso
PROT DIAG
Profilo
Ulf Bladin currently works at Prolight Diagnostics AB, as Chief Executive Officer & Director, TEQCool AB, as Chairman, SPCIN AB, as Director, UB Management Invest AB, as Director, and Rewell Medical AB, as Partner.
Mr. Bladin also formerly worked at DentoSystem Scandinavia AB, as Chief Executive Officer, Pfizer Inc., as Marketing Director, SpectraCure AB, as Independent Director, Lumito AB, as Independent Director, Cardeon AB (Old), as Director, Cardeon AB, as Director, HYCOR Biomedical, Inc., as Vice President-EMEA Region & General Manager from 2016 to 2018, Merck & Co., Inc., as Principal, Phadia AB, as Vice President-Marketing & Health Economy from 2010 to 2011, and Thermo Fisher Scientific, Inc., as VP-Europe Commercial Operations.
Mr. Bladin received his undergraduate degree from Karolinska Institutet and undergraduate degree and graduate degree from Stockholm School of Economics.
Posizioni attive di Ulf Bladin
| Società | Posizione | Inizio |
|---|---|---|
| PROT DIAG | Amministratore Delegato | 01/07/2020 |
TEQCool AB
 TEQCool AB TEQCool AB is a Swedish medical technology company specializing in a patented, non-invasive brain cooling therapy that rapidly and precisely reduces brain temperature via the nasal cavity ’ s natural heat exchange system. The company is based in Lund, Sweden. The company’s approach uses balloon catheters placed intranasally to lower brain temperature by approximately 2ºC within one hour, enabling fast, targeted, and safe temperature management without surgery or deep sedation. This therapy is intended to reduce brain metabolism, oxygen demand, and fever in neurocritical care patients, aiming to prevent secondary brain injury and support neurological recovery. TEQCool’s technology is designed for patients with severe brain injuries and neurogenic fever in conditions such as traumatic brain injury, subarachnoid hemorrhage, status epilepticus, stroke, acute encephalopathy, neonatal hypoxic-ischemic encephalopathy, cardiac arrest, and migraine. The system includes a single-use nasal cooling kit and an adjustable cooling device that allows clinicians to personalize treatment with real-time temperature monitoring. The CEO of the company is Johan Ingemansson. | Presidente | - |
UB Management Invest AB | Direttore/Membro del Consiglio | - |
SPCIN AB | Direttore/Membro del Consiglio | - |
Rewell Medical AB | Corporate Officer/Principal | 01/01/2019 |
Precedenti posizioni note di Ulf Bladin
| Società | Posizione | Fine |
|---|---|---|
| CARDEON AB | Direttore/Membro del Consiglio | 01/01/2023 |
HYCOR Biomedical, Inc.
 HYCOR Biomedical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic products | Corporate Officer/Principal | 01/01/2018 |
Phadia AB
 Phadia AB Chemicals: Major DiversifiedProcess Industries Manufactures chemicals, instruments and apparatus & wholesales measuring and precision instruments | Public Communications Contact | 01/01/2011 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░ | ░░░░░░░ ░ ░░░░░░░░░ | - |
Formazione di Ulf Bladin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
HYCOR Biomedical, Inc.
HYCOR Biomedical, Inc. Medical SpecialtiesHealth Technology Develops and markets medical diagnostic products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phadia AB
Phadia AB Chemicals: Major DiversifiedProcess Industries Manufactures chemicals, instruments and apparatus & wholesales measuring and precision instruments | Process Industries |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
SpectraCure AB
 SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment | Electronic Technology |
Prolight Diagnostics AB
 Prolight Diagnostics AB Medical SpecialtiesHealth Technology Develops biomedical devices | Health Technology |
DentoSystem Scandinavia AB
 DentoSystem Scandinavia AB Medical/Nursing ServicesHealth Services Provides dental care services | Health Services |
Lumito AB
 Lumito AB Medical SpecialtiesHealth Technology Develops, manufactures, and licenses imaging based on nanoparticles | Health Technology |
SPCIN AB | |
Cardeon AB (Old)
 Cardeon AB (Old) Financial ConglomeratesFinance Provides investment services | Finance |
Rewell Medical AB | |
TEQCool AB
TEQCool AB TEQCool AB is a Swedish medical technology company specializing in a patented, non-invasive brain cooling therapy that rapidly and precisely reduces brain temperature via the nasal cavity ’ s natural heat exchange system. The company is based in Lund, Sweden. The company’s approach uses balloon catheters placed intranasally to lower brain temperature by approximately 2ºC within one hour, enabling fast, targeted, and safe temperature management without surgery or deep sedation. This therapy is intended to reduce brain metabolism, oxygen demand, and fever in neurocritical care patients, aiming to prevent secondary brain injury and support neurological recovery. TEQCool’s technology is designed for patients with severe brain injuries and neurogenic fever in conditions such as traumatic brain injury, subarachnoid hemorrhage, status epilepticus, stroke, acute encephalopathy, neonatal hypoxic-ischemic encephalopathy, cardiac arrest, and migraine. The system includes a single-use nasal cooling kit and an adjustable cooling device that allows clinicians to personalize treatment with real-time temperature monitoring. The CEO of the company is Johan Ingemansson. | |
UB Management Invest AB | |
Cardeon AB
 Cardeon AB Financial ConglomeratesFinance Provides investment services | Finance |
